Clinical Trial Update: Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean Fever [Phase 3]

View source ↗

Summary

Phase 3 trial update for Kineret (anakinra) in adult patients with colchicine-resistant familial Mediterranean fever has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Mediterranean Fever

Drugs mentioned

• KINERET (ANAKINRA)

Snippet

Sponsor: Sheba Medical Center | Conditions: Familial Mediterranean Fever | Phase 3 | Status: COMPLETED